Search research articles
Contact Us
Filters
Showing results (21-30 of 255) with videos related to
Page
of 26
Sort By:
Rheumatology (Oxford, England)
|
October 25, 2011
Unsuppressed parathyroid hormone in patients with autoimmune/inflammatory rheumatic diseases: implications for vitamin D supplementation
Pier Paolo Sainaghi, Mattia Bellan, Giuseppina Antonini, et al.
Internal and Emergency Medicine
|
May 17, 2026
Liver involvement in hospitalized patients with West Nile Virus infection
Carlo Smirne, Maria Grazia Crobu, Paolo Ravanini, et al.
Internal and Emergency Medicine
|
August 4, 2016
Natural history and risk stratification of patients undergoing non-invasive ventilation in a non-ICU setting for severe COPD exacerbations
Pier Paolo Sainaghi, Azzurra Re, Mattia Bellan, et al.
European Journal of Gastroenterology & Hepatology
|
July 29, 2016
Influence of age on sex-related differences among patients with hepatitis C
Michela E Burlone, Anita R Pedrinelli, Paola Giarda, et al.
Current Opinion in Investigational Drugs (London, England : 2000)
|
March 3, 2007
Valopicitabine dihydrochloride:a specific polymerase inhibitor of hepatitis C virus
Pierluigi Toniutto, Carlo Fabris, Davide Bitetto, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
March 22, 2020
Eosinophilic gastroenteritis in pregnancy: A review of the literature
Roberta Amadori, Viviana Stampini, Rachele Rapetti, et al.
Transplantation
|
February 18, 2004
Favourable outcome of adefovir-dipivoxil treatment in acute de novo hepatitis B after liver transplantation
Pierluigi Toniutto, Elisabetta Fumo, Maja Caldato, et al.
Internal and Emergency Medicine
|
July 9, 2024
The evolving landscape of autoimmune hepatitis: an ambispective cohort study
Cristina Rigamonti, Irene Giacone, Giulia Francesca Manfredi, et al.
Idrugs : the Investigational Drugs Journal
|
October 2, 2008
R-1626, a specific oral NS5B polymerase inhibitor of hepatitis C virus
Pierluigi Toniutto, Carlo Fabris, Davide Bitetto, et al.
Pharmacology Research & Perspectives
|
June 21, 2021
Sofosbuvir-based therapies in genotype 2 hepatitis C virus cirrhosis: A real-life experience with focus on ribavirin dose
Carlo Smirne, Antonio D'Avolio, Mattia Bellan, et al.
Page
of 26
Search research articles
Search
Showing results (21-30 of 255) with videos related to
Sort By:
Page
of 26
Rheumatology (Oxford, England)
|
October 25, 2011
Unsuppressed parathyroid hormone in patients with autoimmune/inflammatory rheumatic diseases: implications for vitamin D supplementation
Pier Paolo Sainaghi, Mattia Bellan, Giuseppina Antonini, et al.
Internal and Emergency Medicine
|
May 17, 2026
Liver involvement in hospitalized patients with West Nile Virus infection
Carlo Smirne, Maria Grazia Crobu, Paolo Ravanini, et al.
Internal and Emergency Medicine
|
August 4, 2016
Natural history and risk stratification of patients undergoing non-invasive ventilation in a non-ICU setting for severe COPD exacerbations
Pier Paolo Sainaghi, Azzurra Re, Mattia Bellan, et al.
European Journal of Gastroenterology & Hepatology
|
July 29, 2016
Influence of age on sex-related differences among patients with hepatitis C
Michela E Burlone, Anita R Pedrinelli, Paola Giarda, et al.
Current Opinion in Investigational Drugs (London, England : 2000)
|
March 3, 2007
Valopicitabine dihydrochloride:a specific polymerase inhibitor of hepatitis C virus
Pierluigi Toniutto, Carlo Fabris, Davide Bitetto, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
March 22, 2020
Eosinophilic gastroenteritis in pregnancy: A review of the literature
Roberta Amadori, Viviana Stampini, Rachele Rapetti, et al.
Transplantation
|
February 18, 2004
Favourable outcome of adefovir-dipivoxil treatment in acute de novo hepatitis B after liver transplantation
Pierluigi Toniutto, Elisabetta Fumo, Maja Caldato, et al.
Internal and Emergency Medicine
|
July 9, 2024
The evolving landscape of autoimmune hepatitis: an ambispective cohort study
Cristina Rigamonti, Irene Giacone, Giulia Francesca Manfredi, et al.
Idrugs : the Investigational Drugs Journal
|
October 2, 2008
R-1626, a specific oral NS5B polymerase inhibitor of hepatitis C virus
Pierluigi Toniutto, Carlo Fabris, Davide Bitetto, et al.
Pharmacology Research & Perspectives
|
June 21, 2021
Sofosbuvir-based therapies in genotype 2 hepatitis C virus cirrhosis: A real-life experience with focus on ribavirin dose
Carlo Smirne, Antonio D'Avolio, Mattia Bellan, et al.
Page
of 26